Gemma Frisius Fund
Leuvenkuleuven.be
Overview
Gemma Frisius Fund is a seed capital fund established as a joint venture between KU Leuven, KBC Private Equity, and BNP Paribas Fortis Private Equity to stimulate the creation and growth of KU Leuven spin-off companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Runeasi | Feb 2026 | Seed | Co-investor |
| Runeasi | Feb 2026 | VC Round | Co-investor |
| Aspect Analytics | Sep 2025 | Series A | Co-investor |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| Augustine Therapeutics | Jun 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.